Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Not applicableLooking for participantsNCT07401199
What this trial is testing

Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

Who this might be right for
Gastric Cancer (GC)Locally Advanced Gastric Cancer
Qun Zhao 2,000
Testing effectiveness (Phase 2)WithdrawnNCT05371860
What this trial is testing

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Armando Giuliano
Testing effectiveness (Phase 2)Study completedNCT04775953
What this trial is testing

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcal Bacteraemia
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableLooking for participantsNCT05505357
What this trial is testing

Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 533
Not applicableActive Not RecruitingNCT03289195
What this trial is testing

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 31
Not applicableNo Longer AvailableNCT04501757
What this trial is testing

Naxitamab and GM-CSF in People With Neuroblastoma

Who this might be right for
High-Risk Neuroblastoma
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT04101851
What this trial is testing

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Who this might be right for
Breast Cancer FemaleBreast Cancer
Toralf Reimer, MD PhD 350
Not applicableUnknownNCT03474341
What this trial is testing

Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+1 more
UMC Utrecht 200
Testing effectiveness (Phase 2)Study completedNCT01266083
What this trial is testing

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Sellas Life Sciences Group 22
Not applicableLooking for participantsNCT06299202
What this trial is testing

Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Hospices Civils de Lyon 100
Not applicableStudy completedNCT00896129
What this trial is testing

Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 448
Post-approval studies (Phase 4)Not Yet RecruitingNCT07093931
What this trial is testing

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 468
Not applicableNot Yet RecruitingNCT07799337
What this trial is testing

IRELAND Trial: A Translational Biomarker and Exercise Study During Neoadjuvant Breast Cancer Therapy

Who this might be right for
Breast NeoplasmsBreast Cancer
National University of Ireland, Galway, Ireland 250
Testing effectiveness (Phase 2)Looking for participantsNCT07507318
What this trial is testing

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

Who this might be right for
Diffuse Large B-Cell Lymphoma
Rong Tao 69
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Not applicableUnknownNCT03351959
What this trial is testing

Complete Pathologic Response Rectal Cancers

Who this might be right for
Rectal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,000
Not applicableUnknownNCT02348502
What this trial is testing

Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412171
What this trial is testing

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Who this might be right for
Upper Tract Urothelial Carcinoma
Peking University Third Hospital 40
Not applicableUnknownNCT01951521
What this trial is testing

RECTAL BOOST Study

Who this might be right for
Rectal Cancer
UMC Utrecht 128
Next Page